(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEOMBI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEOMBI

ST13

US500000088689188

Class

5

Filing

88689188

Registration

6932910

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/27/2022

Trademark type

Word

Nice classes

5

Filing date

11/12/2019

Registration date

12/27/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/27/2022

Last transaction

12/27/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Södertälje, SE

Examiner

COLTON, BRITTANY

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AstraZeneca AB

Representatives

Cara M. Kearney AstraZeneca Pharmaceuticals LP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for use in the prevention and treatment of respiratory diseases and disorders

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/27/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/27/2022

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

11/23/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/23/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

11/10/2022

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

11/10/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/10/2022

PUBO

PUBLISHED FOR OPPOSITION

05/10/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/20/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/05/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/17/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/17/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/17/2022

ALIE

ASSIGNED TO LIE

02/17/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/15/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/15/2021

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/15/2021

CNSI

SUSPENSION INQUIRY WRITTEN

10/15/2021

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

07/30/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/22/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/22/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/22/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/22/2021

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

07/15/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/08/2020

GNSL

LETTER OF SUSPENSION E-MAILED

09/08/2020

CNSL

SUSPENSION LETTER WRITTEN

09/08/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/15/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/14/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/14/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/24/2020

GNRT

NON-FINAL ACTION E-MAILED

02/24/2020

CNRT

NON-FINAL ACTION WRITTEN

02/24/2020

DOCK

ASSIGNED TO EXAMINER

02/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/19/2019

NWAP

NEW APPLICATION ENTERED

11/15/2019

Continuous trademark protection

Get notified about every new filing that threatens NEOMBI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.